Docusign (NASDAQ:DOCU) Director Teresa Briggs Sells 548 Shares of Stock

Docusign Inc. (NASDAQ:DOCU) Director Teresa Briggs sold 548 shares of the company’s stock in a transaction dated Thursday, September 10th. The shares were sold at an average price of $64.60, for a total transaction of $35,400.80. Following the transaction, the director directly owned 10,811 shares of the company’s stock, valued at approximately $698,390.60. This trade represents a 4.82% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Docusign Trading Down 0.2%

Docusign stock opened at $65.65 on Friday. The firm has a market cap of $12.27 billion, a P/E ratio of 40.03, a P/E/G ratio of 2.48 and a beta of 0.90. Docusign Inc. has a 1-year low of $40.16 and a 1-year high of $86.65. The firm has a 50-day moving average of $57.75 and a 200-day moving average of $50.61.

Docusign (NASDAQ:DOCU) last released its quarterly earnings results on Thursday, September 3rd. The company reported $1.16 EPS for the quarter, beating analysts’ consensus estimates of $1.09 by $0.07. Docusign had a return on equity of 18.29% and a net margin of 9.82%.The business had revenue of $875.75 million during the quarter, compared to analyst estimates of $867.22 million. During the same quarter in the prior year, the company posted $0.30 EPS. Docusign’s quarterly revenue was up 9.4% compared to the same quarter last year. Research analysts forecast that Docusign Inc. will post 2.1 earnings per share for the current fiscal year.

Trending Headlines about Docusign

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Docusign reported quarterly earnings and revenue above analyst estimates, while revenue grew 9.4% year over year. Management also highlighted margin gains, stronger cash flow and continued IAM adoption. Docusign Declines After Beating Q2 Earnings and Revenue Estimates
• Positive Sentiment: The IAM platform now represents 15.1% of annual recurring revenue, suggesting Docusign is using AI to expand beyond traditional electronic signatures and potentially increase customer value. Docusign Q2 2027 Earnings Call Transcript
• Positive Sentiment: Docusign and Stephen Curry’s UNDERRATED Golf announced a “Where Deals Get Done” partnership. The marketing agreement may support brand visibility, although its direct financial impact was not disclosed. Stephen Curry’s UNDERRATED Golf and Docusign Partnership
• Neutral Sentiment: Reported short interest was zero shares, indicating little evidence of an active short-selling position or near-term short-squeeze potential.
• Negative Sentiment: DOCU declined despite the earnings and revenue beat, suggesting investors may have already priced in the strong results or remain cautious about the pace of IAM adoption and future growth. Docusign Declines After Earnings Beat
• Negative Sentiment: Director Peter Solvik sold 46,000 shares worth approximately $3.0 million, reducing his holdings by 48.14%. Director Teresa Briggs also sold shares, though her transaction was executed under a pre-arranged Rule 10b5-1 plan. These sales can weigh on sentiment, even though they do not necessarily signal deteriorating fundamentals.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the company. Jefferies Financial Group upped their price target on Docusign from $45.00 to $50.00 and gave the stock a “hold” rating in a research note on Friday, June 5th. Wedbush lowered their price objective on Docusign from $60.00 to $58.00 and set a “neutral” rating for the company in a research report on Friday, June 5th. Weiss Ratings upgraded shares of Docusign from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, August 25th. BTIG Research upped their target price on shares of Docusign from $60.00 to $75.00 and gave the stock a “buy” rating in a research report on Wednesday, September 2nd. Finally, Citizens Jmp reiterated a “market outperform” rating and issued a $86.00 price target on shares of Docusign in a research note on Friday, September 4th. Three research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $67.33.

Institutional Trading of Docusign

Several hedge funds and other institutional investors have recently made changes to their positions in DOCU. Modus Advisors LLC purchased a new position in Docusign during the fourth quarter valued at $27,000. Cary Street Partners Investment Advisory LLC grew its stake in shares of Docusign by 309.5% in the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 561 shares of the company’s stock worth $38,000 after acquiring an additional 424 shares during the last quarter. Basepoint Wealth LLC purchased a new stake in shares of Docusign in the fourth quarter worth $39,000. WealthCollab LLC increased its holdings in shares of Docusign by 372.4% during the first quarter. WealthCollab LLC now owns 855 shares of the company’s stock valued at $41,000 after acquiring an additional 674 shares in the last quarter. Finally, Virtus Advisers LLC bought a new position in shares of Docusign during the second quarter valued at $47,000. Hedge funds and other institutional investors own 77.64% of the company’s stock.

Docusign Company Profile

DocuSign, Inc is a provider of digital agreement management and electronic signature solutions. Its platform enables individuals and organizations to prepare, send, sign, manage and store agreements electronically, helping businesses replace paper-based contracting processes with digital workflows.

The company’s products and services include DocuSign eSignature, which supports electronic signing and authentication, as well as tools for contract lifecycle management, agreement preparation, identity verification, notarial services and workflow automation.